[The treatment of women with dyshormonal myocardiodystrophy].
Iakimenko-Vasiutina. E A EA
Key Findings
- Cryogenic treatment plus thymalin improved outcomes in women with dyshormonal myocardiodystrophy
- Extracardiac (outside the heart) symptoms were significantly reduced
- Cellular and humoral immunity indices returned toward normal levels
Practical Outcomes
- The results hint that thymalin might have immune‑supporting effects, but the study’s narrow focus and lack of protocol details make it unsuitable as a general longevity or performance supplement. Biohackers should treat this as preliminary evidence and wait for broader, well‑controlled trials before incorporating thymalin into everyday regimens.
Summary
A study used a cold‑based therapy together with the peptide thymalin on women with a rare heart‑muscle disorder linked to hormonal issues and uterine growths. The combination appeared to improve heart‑related symptoms and boost immune system markers, but the research is very specific and doesn’t give clear dosing or broader health advice.
Abstract
Cryogenic treatment in association with thymalin was used in women suffering of dyshormonal myocardiodystrophy associated with hyperplastic processes of the uterus. This treatment proved efficient and furthered significant reduction of disappearance of both extracardiac manifestations of the disease. Under the effect of thymalin indices of cellular and humoral immunity were restored.
Study Information
pubmed
1990